Company intelligence / Profile preview

Genechem

Shanghai, Shanghai, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Genechem is a leading biotechnology company based in Shanghai that focuses on novel drug target discovery and the development of cell therapies and antibodies. The company leverages its proprietary Good Research Practice (GRP) platform, which integrates a large network of research hospitals and advanced genetic tools, to translate clinical research into oncology therapeutics. Genechem has several CAR-T programs in Phase 2 clinical trials, including treatments for liver cancer and lymphoma.

Therapeutic areas: OncologyImmunology
Modalities: CAR-T cell therapyT cell receptor engineered T cell therapyMonoclonal antibodyBispecific monoclonal antibodyGene therapyCell therapy
Industry: Biotech

Partnerships

I-Mab BiopharmaXijing Hospital

Beyond the preview

Go deeper on Genechem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genechem.

Explore the full profile